Get started
Artivion, Inc.Artivion, Inc.Artivion, Inc.

Artivion, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

CYL chart


Full chart

CYL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.66 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.36 EUR
Net income (FY)
‪−12.88 M‬ EUR
Revenue (FY)
‪375.32 M‬ EUR
Shares float
‪44.83 M‬
Beta (1Y)
0.81

Employees


Employees (FY)
‪1.6 K‬
Change (1Y)
+100 +6.67%
Revenue / Employee (1Y)
‪234.57 K‬ EUR
Net income / Employee (1Y)
‪−8.05 K‬ EUR

About Artivion, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
James Patrick Mackin
Website
artivion.com
Headquarters
Kennesaw
Founded
1984
ISIN
US2289031005
FIGI
BBG01JJ4T621
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

Check out other big names from the same industry as CYL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CYL news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs with CYL exposure


IJR
iShares Core S&P Small Cap ETF
Weight
0.11%
Market value
‪97.93 M‬
USD
IWM
iShares Russell 2000 ETF
Weight
0.05%
Market value
‪37.60 M‬
USD
SPSM
SPDR Portfolio S&P 600 Small Cap ETF
Weight
0.11%
Market value
‪14.39 M‬
USD
IJT
iShares S&P Small-Cap 600 Growth ETF
Weight
0.23%
Market value
‪14.16 M‬
USD
IWO
iShares Russell 2000 Growth ETF
Weight
0.08%
Market value
‪11.02 M‬
USD
IHI
iShares U.S. Medical Devices ETF
Weight
0.20%
Market value
‪8.47 M‬
USD
SCHA
Schwab U.S. Small-Cap ETF
Weight
0.04%
Market value
‪8.25 M‬
USD
SLYG
SPDR S&P 600 Small Cap Growth ETF
Weight
0.23%
Market value
‪8.10 M‬
USD
VTWO
Vanguard Russell 2000 ETF
Weight
0.06%
Market value
‪7.84 M‬
USD
NANC
Unusual Whales Subversive Democratic Trading ETF
Weight
3.01%
Market value
‪7.76 M‬
USD
VIOO
Vanguard S&P Small-Cap 600 ETF
Weight
0.12%
Market value
‪5.54 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of CYL is 35.00 EUR — it has decreased by −0.58% in the past 24 hours. Watch Artivion, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Artivion, Inc. stocks are traded under the ticker CYL.
CYL stock has risen by 0.44% compared to the previous week, the month change is a −7.37% fall, over the last year Artivion, Inc. has showed a 47.68% increase.
We've gathered analysts' opinions on Artivion, Inc. future price: according to them, CYL price has a max estimate of 42.73 EUR and a min estimate of 33.16 EUR. Watch CYL chart and read a more detailed Artivion, Inc. stock forecast: see what analysts think of Artivion, Inc. and suggest that you do with its stocks.
CYL reached its all-time high on Aug 22, 2025 with the price of 38.35 EUR, and its all-time low was 11.60 EUR and was reached on Oct 30, 2023. View more price dynamics on CYL chart.
See other stocks reaching their highest and lowest prices.
CYL stock is 2.17% volatile and has beta coefficient of 0.81. Track Artivion, Inc. stock price on the chart and check out the list of the most volatile stocks — is Artivion, Inc. there?
Today Artivion, Inc. has the market capitalization of ‪1.63 B‬, it has increased by 3.53% over the last week.
Yes, you can track Artivion, Inc. financials in yearly and quarterly reports right on TradingView.
Artivion, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
CYL earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.00 EUR resulting in a 799.95% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about Artivion, Inc. earnings.
Artivion, Inc. revenue for the last quarter amounts to ‪95.90 M‬ EUR, despite the estimated figure of ‪91.71 M‬ EUR. In the next quarter, revenue is expected to reach ‪94.11 M‬ EUR.
CYL net income for the last quarter is ‪1.14 M‬ EUR, while the quarter before that showed ‪−465.87 K‬ EUR of net income which accounts for 344.72% change. Track more Artivion, Inc. financial stats to get the full picture.
No, CYL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 3, 2025, the company has ‪1.6 K‬ employees. See our rating of the largest employees — is Artivion, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Artivion, Inc. EBITDA is ‪43.25 M‬ EUR, and current EBITDA margin is 13.30%. See more stats in Artivion, Inc. financial statements.
Like other stocks, CYL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Artivion, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Artivion, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Artivion, Inc. stock shows the buy signal. See more of Artivion, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.